Medical device procedures
Medicare volume, surgeons, growth, site of care and device makers for 52 device-driven procedures
Each procedure page adds up the Medicare market across the states MedaRep covers: its growth, where the cases are done, how its surgeons are turning over, which companies engage them and who holds FDA clearances in the category.
- Largest orthopedic, spine and wound procedures by 2024 Medicare fee-for-service cases: debridement & negative-pressure wound therapy (3,389,687), skin substitutes & wound grafts (504,012), decompression & minimally invasive spine (105,318).
- Reported by CMS. Fee-for-service alone falls as patients move to Medicare Advantage, so its trend understates the market.
- Forecast record: one year ahead, MedaRep’s market forecasts have been off by 4% overall, weighted by case volume; each page gives its own procedure’s record.
Growing fastest since 2019
- CGM & insulin pump management+22%/yr
- Skin substitutes & wound grafts+15%/yr
- Aneurysm & intracranial embolization+13%/yr
- SI joint fusion+13%/yr
- LAA occlusion & loop recorders+10%/yr
Procedures with 2,000+ Medicare cases in both years; yearly growth in Medicare fee-for-service cases.
Strongest outlook to 2030
- Tumor & fibroid embolization+15%/yr
- EP ablation+11%/yr
- Aneurysm & intracranial embolization+11%/yr
- CGM & insulin pump management+11%/yr
- LAA occlusion & loop recorders+10%/yr
MedaRep's forecast of Medicare fee-for-service cases, for procedures it has forecast within 15% a year ahead.
Moving out of the hospital fastest
- Tumor & fibroid embolization+53 pts to 56%
- Skin substitutes & wound grafts+31 pts to 70%
- Peripheral nerve stimulation & intrathecal pumps+24 pts to 59%
- SI joint fusion+21 pts to 45%
- Spinal cord & DRG stimulation+19 pts to 60%
Share of surgeons' claims in surgery centers and offices, CMS claim summary.
Most new surgeons since 2021
- Skin substitutes & wound grafts1,477 (71%)
- CGM & insulin pump management2,855 (42%)
- Debridement & negative-pressure wound therapy4,993 (35%)
- Sleep apnea & airway implants46 (30%)
- Sinus surgery & balloon dilation383 (29%)
Surgeons who started billing it, as a share of today's.
Spine & neurosurgery
| Procedure | Surgeons | Medicare FFS | Growth since 2019 | Out of hospital | Forecast |
|---|---|---|---|---|---|
| Decompression & minimally invasive spine | 2,544 | 105,318−5.9%/yr | −5.9%/yr | 8% | 112,600 in 2030+1.1%/yr |
| Lumbar fusion | 2,352 | 95,082−1.5%/yr | −1.5%/yr | 2% | 107,700 in 2030+2.1%/yr |
| Cervical fusion & disc arthroplasty | 962 | 47,639−4%/yr | −4%/yr | 4% | 52,600 in 2030+1.7%/yr |
| Kyphoplasty & vertebroplasty | 453 | 42,837−5.7%/yr | −5.7%/yr | 32% | 44,800 in 2030+0.7%/yr |
| SI joint fusion | 147 | 7,710+13%/yr | +13%/yr | 45% | 14,700 in 2030+11%/yr |
Biologics & wound care
| Procedure | Surgeons | Medicare FFS | Growth since 2019 | Out of hospital | Forecast |
|---|---|---|---|---|---|
| Debridement & negative-pressure wound therapy | 14,239 | 3,389,687−0.3%/yr | −0.3%/yr | 44% | 3,953,800 in 2030+2.6%/yr |
| Skin substitutes & wound grafts | 2,068 | 504,012+15%/yr | +15%/yr | 70% | 807,400 in 2030+8.2%/yr |
| Bone graft & orthobiologics | 545 | 22,075−9.8%/yr | −9.8%/yr | 2% | 22,500 in 2030+0.3%/yr |
Pain & neuromodulation
| Procedure | Surgeons | Medicare FFS | Growth since 2019 | Out of hospital | Forecast |
|---|---|---|---|---|---|
| Radiofrequency ablation (facet, genicular, basivertebral) | 5,025 | 365,4360%/yr | 0%/yr | 78% | 446,400 in 2030+3.4%/yr |
| Peripheral nerve stimulation & intrathecal pumps | 597 | 37,794+7.9%/yr | +7.9%/yr | 59% | 64,500 in 2030+9.3%/yr |
| Spinal cord & DRG stimulation | 668 | 24,248−3.1%/yr | −3.1%/yr | 60% | 28,100 in 2030+2.5%/yr |
Vascular & endovascular
| Procedure | Surgeons | Medicare FFS | Growth since 2019 | Out of hospital | Forecast |
|---|---|---|---|---|---|
| Peripheral arterial intervention | 1,321 | 182,726−5.9%/yr | −5.9%/yr | 61% | 215,300 in 2030+2.8%/yr |
| Superficial venous ablation | 1,980 | 166,794−4.1%/yr | −4.1%/yr | 96% | 191,600 in 2030+2.3%/yr |
| Dialysis access | 1,721 | 161,268−13%/yr | −13%/yr | 64% | 158,700 in 2030−0.3%/yr |
| Thrombectomy, IVC filters & venous stents | 389 | 47,332+0.1%/yr | +0.1%/yr | 18% | 62,700 in 2030+4.8%/yr |
| Carotid revascularization | 741 | 36,694−5%/yr | −5%/yr | 0% | 40,000 in 2030+1.5%/yr |
| Aortic endografts (EVAR/TEVAR) | 89 | 13,204−6.8%/yr | −6.8%/yr | 0% | 13,800 in 2030+0.7%/yr |
General & bariatric surgery
| Procedure | Surgeons | Medicare FFS | Growth since 2019 | Out of hospital | Forecast |
|---|---|---|---|---|---|
| Hernia repair | 2,306 | 187,629−3%/yr | −3%/yr | 7% | 210,200 in 2030+1.9%/yr |
| Cholecystectomy & appendectomy | 2,560 | 131,995−5.4%/yr | −5.4%/yr | 2% | 140,500 in 2030+1%/yr |
| Colorectal resection | 232 | 52,254−5.2%/yr | −5.2%/yr | 0% | 53,600 in 2030+0.4%/yr |
| Antireflux & hiatal hernia surgery | 375 | 23,396−1.8%/yr | −1.8%/yr | 0% | 28,800 in 2030+3.5%/yr |
| Breast reconstruction | 66 | 13,660−6.4%/yr | −6.4%/yr | 4% | 17,400 in 2030+4.1%/yr |
| Bariatric surgery | 15 | 4,952−17%/yr | −17%/yr | 0% | 3,750 in 2030−4.5%/yr |
Urology & women's health
| Procedure | Surgeons | Medicare FFS | Growth since 2019 | Out of hospital | Forecast |
|---|---|---|---|---|---|
| Kidney stone management | 3,401 | 159,938−1.4%/yr | −1.4%/yr | 15% | 172,300 in 2030+1.2%/yr |
| BPH procedures | 2,196 | 155,142−6.4%/yr | −6.4%/yr | 38% | 148,000 in 2030−0.8%/yr |
| Hysterectomy, hysteroscopy & ablation | 906 | 83,637−1.3%/yr | −1.3%/yr | 16% | 95,100 in 2030+2.2%/yr |
| Incontinence, prolapse & sacral neuromodulation | 1,058 | 73,050−1.4%/yr | −1.4%/yr | 17% | 83,900 in 2030+2.3%/yr |
| Prostatectomy & nephrectomy | 592 | 37,032−1.1%/yr | −1.1%/yr | 0% | 45,600 in 2030+3.5%/yr |
ENT & sleep
| Procedure | Surgeons | Medicare FFS | Growth since 2019 | Out of hospital | Forecast |
|---|---|---|---|---|---|
| Sinus surgery & balloon dilation | 1,305 | 139,655−2.1%/yr | −2.1%/yr | 86% | 173,800 in 2030+3.7%/yr |
| Ear tubes & middle ear surgery | 69 | 8,303−6.6%/yr | −6.6%/yr | 48% | 8,360 in 2030+0.1%/yr |
| Sleep apnea & airway implants | 151 | 5,383+26%/yr | +26%/yr | 5% | 5,940 in 2030+1.6%/yr |
| Cochlear implants | 114 | 3,948+5.5%/yr | +5.5%/yr | 12% | 5,240 in 2030+4.8%/yr |
Interventional oncology & breast
| Procedure | Surgeons | Medicare FFS | Growth since 2019 | Out of hospital | Forecast |
|---|---|---|---|---|---|
| Breast biopsy & localization | 3,675 | 218,500−1.8%/yr | −1.8%/yr | 29% | 243,500 in 2030+1.8%/yr |
| Tumor & fibroid embolization | 314 | 18,000+6%/yr | +6%/yr | 56% | 42,100 in 2030+15%/yr |
| Tumor ablation | 63 | 8,642+0.4%/yr | +0.4%/yr | 0% | 12,000 in 2030+5.6%/yr |
Diabetes & referred DME
| Procedure | Surgeons | Medicare FFS | Growth since 2019 | Out of hospital | Forecast |
|---|---|---|---|---|---|
| CGM & insulin pump management | 6,808 | 893,092+22%/yr | +22%/yr | 84% | 1,632,200 in 2030+11%/yr |
Cardiac rhythm & electrophysiology
| Procedure | Surgeons | Medicare FFS | Growth since 2019 | Out of hospital | Forecast |
|---|---|---|---|---|---|
| Pacemaker, ICD & CRT implantation | 3,039 | 159,222−3.4%/yr | −3.4%/yr | 3% | 164,900 in 2030+0.6%/yr |
| EP ablation | 2,323 | 129,831+7.2%/yr | +7.2%/yr | 0% | 241,600 in 2030+11%/yr |
| LAA occlusion & loop recorders | 2,939 | 120,836+10%/yr | +10%/yr | 18% | 217,900 in 2030+10%/yr |
Interventional & structural cardiology
| Procedure | Surgeons | Medicare FFS | Growth since 2019 | Out of hospital | Forecast |
|---|---|---|---|---|---|
| Coronary intervention (PCI) | 5,056 | 218,309−6.5%/yr | −6.5%/yr | 2% | 236,300 in 2030+1.3%/yr |
| Structural heart (TAVR, TEER) | 2,849 | 63,491+3.8%/yr | +3.8%/yr | 0% | 90,800 in 2030+6.2%/yr |
| Mechanical circulatory support | 56 | 17,228−4.4%/yr | −4.4%/yr | 0% | 19,300 in 2030+1.9%/yr |
| PFO & septal closure | 10 | 1,097+2.2%/yr | +2.2%/yr | 0% | 1,130 in 2030+0.5%/yr |
Neurovascular & neurosurgical devices
| Procedure | Surgeons | Medicare FFS | Growth since 2019 | Out of hospital | Forecast |
|---|---|---|---|---|---|
| Aneurysm & intracranial embolization | 398 | 14,006+13%/yr | +13%/yr | 0% | 25,900 in 2030+11%/yr |
| Stroke thrombectomy | 446 | 12,543+1.7%/yr | +1.7%/yr | 0% | 14,600 in 2030+2.5%/yr |
| DBS & VNS | 156 | 9,717−3.7%/yr | −3.7%/yr | 1% | 14,000 in 2030+6.2%/yr |
| CSF shunts | 56 | 5,163−4.8%/yr | −4.8%/yr | 0% | 6,290 in 2030+3.3%/yr |
Ophthalmology
| Procedure | Surgeons | Medicare FFS | Growth since 2019 | Out of hospital | Forecast |
|---|---|---|---|---|---|
| Cataract & MIGS | 8,406 | 1,858,437−1.3%/yr | −1.3%/yr | 83% | 2,081,700 in 2030+1.9%/yr |
| Vitreoretinal surgery | 1,078 | 78,831−3.2%/yr | −3.2%/yr | 65% | 82,600 in 2030+0.8%/yr |
GI & pulmonary endoscopy
| Procedure | Surgeons | Medicare FFS | Growth since 2019 | Out of hospital | Forecast |
|---|---|---|---|---|---|
| Colonoscopy & upper endoscopy | 17,732 | 3,622,736−2.9%/yr | −2.9%/yr | 46% | 3,877,600 in 2030+1.1%/yr |
| ERCP & endoscopic ultrasound | 1,734 | 112,761−1.2%/yr | −1.2%/yr | 2% | 137,600 in 2030+3.4%/yr |
| Bronchoscopy & lung nodule | 1,570 | 101,765+4.5%/yr | +4.5%/yr | 0% | 172,300 in 2030+9.2%/yr |
- Surgeons and Medicare fee-for-service cases: 2024 figures summed over the states where each procedure tops 100 cases a year.
- The line: Medicare fee-for-service cases since 2019.
- Out of hospital: surgeons’ claims in surgery centers and offices in CMS’s latest claim summary.
- Outlook: MedaRep’s forecast.
Markets by state · Compare two markets · How the numbers are made